Figure 1.
Concentration‐time profiles of ontamalimab (top panel) and free MAdCAM‐1 (bottom panel) in patients with CD and UC. CD, Crohn's disease; MAdCAM‐1, mucosal addressin cell adhesion molecule‐1; UC, ulcerative colitis.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.